EFFECTIVE TREATMENT METHOD IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE DEPENDING ON THE STATUS OF CITOKIN

dc.contributor.author	Musaev F. T.
dc.contributor.author	Kenjayev O. O.
dc.date.accessioned	2025-12-28T20:21:11Z
dc.date.issued	2025-04-15
dc.description.abstract	This article presents an analysis of the results of anti-inflammatory treatment of chronic obstructive pulmonary disease (COPD) based on changes in the dynamics of indicators of systemic inflammation depending on the type of risk and duration of treatment. Short-term administration of the anti-inflammatory drug roflumilast into the complex therapy of low-risk COPD patients provides a significant decrease in systemic inflammatory activity, which is accompanied by a decrease in the level of anti-inflammatory cytokines (IL-6, IL-8, TNF-α), CRP, fibrinogen.
dc.format	application/pdf
dc.identifier.uri	https://sjird.journalspark.org/index.php/sjird/article/view/1209
dc.identifier.uri	https://asianeducationindex.com/handle/123456789/14024
dc.language.iso	eng
dc.publisher	Journals Park Publishing
dc.relation	https://sjird.journalspark.org/index.php/sjird/article/view/1209/1155
dc.source	Spectrum Journal of Innovation, Reforms and Development; Vol. 38 (2025); 21-27
dc.source	2751-1731
dc.subject	Chronic obstructive pulmonary disease, IL-6, IL-8, TNF-α, CRP, fibrinogen, treatment, roflumilast.
dc.title	EFFECTIVE TREATMENT METHOD IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE DEPENDING ON THE STATUS OF CITOKIN
dc.type	info:eu-repo/semantics/article
dc.type	info:eu-repo/semantics/publishedVersion
dc.type	Peer-reviewed Article

item.page.files

pagination.showing.labelpagination.showing.detail

item.page.filesection.name: t_2025_effective_treatment_method_in_chronic_ob.pdf
item.page.filesection.size: 253.44 KB
item.page.filesection.format: Adobe Portable Document Format